The erythrocyte sedimentation rate (ESR) is a medical in vitro clinical tool, formally introduced in evidenced-based medicine during the twentieth century1,2,3,4. It is currently used worldwide as a nonspecific inflammatory test, or to monitor the evolution of some specific conditions5,6,7,8. This is mainly due to an increase in the fibrinogen concentration, but also in other plasma components such as IgM1,9,10,11. According to the current Westergren standard protocol, ESR values are reported as the measurement of the cell-free plasma layer at a given time point (30 min or 1 h) after leaving a vertical tube of a typical size of 20 cm vertically at rest12. However, this measurement method has been criticized since qualitatively different stages in the sedimentation process have been reported, including a delay before reaching the maximum settling velocity13. This delay lasts more than 1 h in approximately half of healthy samples14. The velocity during this phase obeys a different scaling than during the second, faster phase of the sedimentation15. Restricting the readout to the average settling velocity during the first hour then compares a different mix of various blood properties between different individuals.
Moreover, it has recently been demonstrated that the usual theoretical considerations behind this protocol were erroneous16,17,18. At physiological hematocrit (above approximately 25%), red blood cells (RBCs) do not sediment as separate aggregates, but rather as a continuous, so-called percolating, network of RBCs17,18, obeying a different set of physical equations than the usually mentioned Stokes sedimentation16,17. It has been shown that considering a physical description based on the time-resolved measurements of the sedimentation (whole curve) was more robust in some novel medical contexts19,20. Moreover, these measurements could be used to shed light on the physical mechanisms altering the ESR in pathologies in which cell shapes are altered19,20. Additionally, a slow ESR can have a useful medical interpretation, as indicated in the measurements of a cohort of neuroacanthocytosis syndrome patients19,20. This article reviews how to practically implement the measurement of physically-meaningful parameters, based on the whole ESR kinetics. More accurately, the method presented here extracts the maximum sedimentation speed Um, the value of which can be corrected to consider the effect of the hematocrit of the donor16,17. This parameter is more accurate and thus more reliable than the traditional measurement16,17,19,20.
In addition, in some fundamental research, instead of monitoring the inflammation state of a given patient, it is interesting to exclude the effect of hematocrit on the ESR21,22,23, or to investigate the role of RBCs in a modified ESR19,20,24,25 between different donors. It might be useful to compare samples which are not directly full blood samples from patients. Therefore, resuspending RBCs with a controlled hematocrit in the autologous plasma, or in a plasma-substituent, might be used as the first step of ESR measurement. For instance, solutions of Dextran 70 kDa with a concentration of 55 mg/mL in phosphate buffered saline (PBS) produces a sedimentation range within the control range for healthy cells19. This manuscript also shows how such steps should be conducted, and that the presented analysis is also relevant in these cases.